Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIK3IP1 divergent transcript (PIK3IP1-DT)
- Target
- PIK3IP1-DT
- Molecular classification
- Other (long non-coding RNA, antisense transcript)
01
Overview
PIK3IP1 divergent transcript (PIK3IP1-DT) refers to a long non-coding RNA initiated from a promoter located downstream and antisense to the PIK3IP1 protein-coding gene. Transcription of PIK3IP1-DT depends on convergent promoter architecture, where transcriptional activity of both PIK3IP1 and the divergent transcript can be positively co-regulated by factors such as the p53-induced transcription factor RFX7[1]. Functional annotation is incomplete: the transcript is missing from many reference gene catalogs and its transcription start site (TSS) is not formally annotated[1][3]. The biological significance and functional mechanisms of PIK3IP1-DT remain largely unknown, with no established role in disease, drug response, or cell biology outside its potential cis-regulatory effects on the host gene, PIK3IP1. No known drugs, biomarkers, or direct clinical relevance is attributed to PIK3IP1-DT[3][4].
- Other names
- PIK3IP1-AS1
02
Mechanism of action
None
03
Biological functions
Not establishedBiological function remains unclearMay participate in transcriptional regulation through mechanisms linked to promoter architecture and transcription factor binding (notably RFX7-dependent regulation in response to p53 signaling)Correlated expression with the protein-coding PIK3IP1 gene suggests a role in cis-regulatory promoter activityNo evidence for involvement in signal transduction, cell proliferation, cell death, or immune response distinct from the host gene
04
Disease associations
UnknownNo established disease associations specifically for PIK3IP1-DTRole not defined despite parent gene PIK3IP1's immunological and cancer relevance
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on PIK3IP1 divergent transcript (PIK3IP1-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PIK3IP1 divergent transcript (PIK3IP1-DT).